Silo Pharma, Inc.
SILO
$0.63
-$0.011-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.54% | -18.70% | 10.82% | 23.01% | 14.60% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.15% | -99.38% | -72.18% | -64.58% | -67.09% |
| Change in Net Operating Assets | -124.17% | 84.33% | -114.33% | -118.03% | -77.54% |
| Cash from Operations | -37.57% | -18.90% | -19.56% | -0.02% | 0.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.78% | 123.48% | 163.44% | 168.53% | 132.97% |
| Cash from Investing | -10.78% | 123.48% | 163.44% | 168.53% | 132.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -66.14% | -- |
| Repurchase of Common Stock | 90.16% | 63.23% | -32.85% | -291.83% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 672.30% | 788.09% | 1,201.26% | -75.88% | -111.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.46% | 104.86% | 138.67% | 150.70% | 54.62% |